Be Part of Advancing the Pharma Innovation
Pharmaceutical innovation in therapeutics is vital to advancing global healthcare, improving patient outcomes, and addressing pressing health challenges. As the demand for cutting-edge solutions grows, the pharma sector is at the forefront of Life Science R&D, playing a crucial role in developing novel therapies, enhancing drug delivery systems, and addressing unmet medical needs across diverse populations.
Investments in pharmaceuticals are pivotal for advancing therapeutic options, strengthening healthcare systems, and ensuring equitable access to life-saving medicines. These efforts not only catalyse scientific discovery but also stimulate economic growth and foster international collaboration.
Get Funding With Nordic Innovators
Our services support organisations that pursue funding for the following types of projects:
- Drug development pipelines: Enabling research into next-generation therapies, including biologics, gene therapies, and advanced treatments for underserved medical conditions.
- Formulation and delivery innovation: Developing cutting-edge drug delivery technologies, such as microneedles, nanocarriers, and precision-release systems.
- Regulatory and clinical advancements: Facilitating regulatory strategy development and clinical trial designs for faster, patient-centric therapeutic approvals.
Key EU Funding Programmes for Pharmaceuticals
It gives grants and equity funding to innovative startups and SMEs with high impact/risk products or services. A unique combination of funding from €0.5 to 17.5 million to support innovative, products, services or business models that can create new markets or disrupt existing ones. New application process - 3 main stages.
Aimed for international projects that accelerate marketable innovative products. It is entry point enabling SMEs to merge and share expertise across borders. The consortium must have partners based in at least two different Eurostars countries. Funding average ranges of 50-75% of project costs.
This programme gives funding to turn research results into innovation opportunities. The goal is to help mature the technologies and develop business cases for the future commercialization. This can be in any field of science/technology and deal with specific challenges in various strategic fields.
Both IA and RIA are main vehicles for project-based collaborative technology development supported by the EC. IA is geared towards advancing innovative solutions towards market readiness and RIA is focused on pushing the boundaries of knowledge through pioneering research.
The programme consists of a combination of both open and challenge driven funding. It supports the exploration of bold ideas for radically new technologies and welcomes the high-risk and interdisciplinary cutting-edge science collaborations that underpin technological breakthroughs.
innovative health initiative
Innovative health initiative is a EU public-private partnership funding health research and innovation.
Organisations in the EU or Horizon Europe-associated countries including universities, research institutions, SMEs can apply for IHI funding. Larger companies may also qualify based on proposal calls.
Relevant Danish funding schemes for Pharmaceuticals
Grand Solutions
The Grand Solutions programme supports ambitious and innovative research and development projects that drive technological advancements and create societal impact. With significant funding opportunities, it fosters collaboration between businesses, research institutions, and public organizations to strengthen Denmark’s innovation ecosystem.
The Innobooster programme helps SMEs and startups turn innovative ideas into competitive solutions by funding development projects with high business potential. Supporting everything from new products to improved processes, Innobooster accelerates growth and strengthens innovation in a broad variety of industries.